U of M researchers look to dogs to better understand intricacies of bone cancer

	Tweet

News Summary
A team led by Dr. Jaime Modiano, a College of Veterinary Medicine and Masonic Cancer center expert in comparative medicine, discovered a gene pattern that distinguishes the more severe form of bone cancer from a less aggressive form in dogs. Dogs are the only other species besides humans that develops this disease spontaneously with any frequency.
Quotes

“Our findings pave the way to develop laboratory tests that can predict the behavior of this tumor in dogs and children at the time of diagnosis,” said Dr. Jaime Modiano, College of Veterinary Medicine and Masonic Cancer Center expert in comparative medicine. “This allows us to tailor individualized therapy to meet the patient’s needs.”

“Patients with less aggressive disease could be treated conservatively, reducing the side effects and the risks associated with treatment, while patients with more aggressive disease could be treated with more intense therapy,” said Modiano. 

A new University of Minnesota discovery may help bone cancer patients fight their disease more effectively, according to new research published in the September issue of Bone.

Bone cancer typically affects children; the course and aggressiveness of the disease can vary from patient to patient and is very difficult to predict. Some patients respond remarkably well to conventional therapies. Their disease shows less aggressive behavior and they can survive for decades without recurrence. Others respond poorly to treatment or their disease comes back rapidly. Often, these patients survive less than five years.

Recently, a team led by Dr. Jaime Modiano, a College of Veterinary Medicine and Masonic Cancer Center expert in comparative medicine, discovered a gene pattern that distinguishes the more severe form of bone cancer from a less aggressive form in dogs. Dogs are the only other species besides humans that develops this disease spontaneously with any frequency.

In fact, dogs are much more likely to develop bone cancer than humans, but according to Modiano – who specializes in the relationship between animal and human disease – human and canine forms of bone cancer are very similar and the gene pattern is an exact match. The discovery of this key differentiating signature may be beneficial in the treatment planning of human bone cancer patients.

“Our findings pave the way to develop laboratory tests that can predict the behavior of this tumor in dogs and children at the time of diagnosis,” said Modiano. “This allows us to tailor individualized therapy to meet the patient’s needs.”

The downstream impact of the findings

University of Minnesota researchers hope to use their findings to develop practical and useful lab tests for humans and for companion animals that will help clinical care providers determine the type of cancer a patient faces, and how aggressive that cancer may be.

Then, depending on which type of cancer a patient has, clinicians could adjust interventions and treatment plans accordingly.

“Patients with less aggressive disease could be treated conservatively, reducing the side effects and the risks associated with treatment, while patients with more aggressive disease could be treated with more intense therapy,” said Modiano.

The study was funded by the National Cancer Institute, the AKC Canine Health Foundation and the Kate Koogler Canine Cancer Fund.

###

Masonic Cancer Center

Masonic Cancer Center, University of Minnesota is part of the University’s Academic Health Center. It is designated by the National Cancer Institute as a comprehensive cancer center for cancer research, treatment, and education.

RELATED STORIES:
Backyard Garden May Yield Leukemia Treatment   Radical Surgery Removes Half of Pelvis, Saves Leg   Children with cancer risk fragile bones   Injured Marines at risk for abnormal bone growth   A New Way to Build Bone   Children with bone cancer at risk for second cancer   Drug Used for Advanced Cancer Could Cause Exposed Bone in Jaw   Yeast unravels effects of chemotherapy drugs   Immune-Based Drug Approved in Europe for Pediatric Cancer Patients   Leukemia risk from chlorination seen mixed   Approved lymphoma drug shows promise in early tests against bone cancer   New study shows positive role physical therapists play in lymphedema diagnois and treatment   Towards more effective treatment for multiple myeloma   Researchers Explore Issues Related to Multiple Myeloma Treatment   Researchers Identify Potential Therapeutic Target in Osteosarcoma   Bone loss seen in kids after stem cell therapy   New Hope for Deadly Childhood Bone Cancer   Several factors affect bone marrow volume reduction   Freezing Bone Cancer Tumors Reduces Pain   Oral Drug Sets New Survival Standard for Bone Marrow Cancer   Children with bone cancer in their arms or legs survival rate improved   Whites at greatest risk for rare bone cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]